Research Discovery: New Insights on Radiation Therapy After Breast Cancer Surgery

This publication reviews two major clinical trials that explored whether some people with early-stage breast cancer can safely receive less radiation treatment after mastectomy surgery. One of the studies looked at whether postmastectomy radiation therapy (PMRT) could sometimes be reduced or omitted in patients whose cancer responded well to chemotherapy.

Radiation therapy after mastectomy is often used to lower the chance that breast cancer will return in the chest wall, nearby lymph nodes, and other parts of the body. However, radiation can also cause side effects and inconvenience. Because cancer treatments have improved over time, researchers wanted to understand whether some patients might still do well with less radiation treatment.

The article focuses on two large studies:

• B-51/RTOG 1304 — studied patients whose lymph node-positive breast cancer became node-negative after chemotherapy before surgery.
• SUPREMO — studied whether chest wall radiation improved outcomes after mastectomy in patients with certain early-stage breast cancers.

How It Works

In the two studies, researchers compared groups of patients who received radiation therapy after mastectomy with groups who did not receive radiation. They tracked outcomes such as:

• Whether the cancer returned
• Survival over time
• Recurrence in the chest wall or nearby lymph nodes
• Spread of cancer to other parts of the body

The article explains that modern breast cancer treatment is complex and personalized. Factors that influence treatment decisions include:

• Number of lymph nodes involved
• How well the cancer responded to chemotherapy
• Type of surgery performed
• Hormone receptor status
• Potential side effects of radiation
• Patient preferences and values

Importantly, the authors caution that “less treatment” is not always simple. Some patients may still benefit from radiation even when their cancer appears relatively low risk.

Key Findings

• Some patients may safely avoid radiation—but not everyone. The studies showed that many patients had very low recurrence rates regardless of whether they received radiation therapy. This suggests that some people may be able to avoid additional radiation after mastectomy without greatly increasing their risk of cancer returning.
• Radiation may still help many intermediate and higher-risk groups. Among patients with lymph node-positive disease, radiation therapy still appeared to reduce the risk of cancer returning.
• The type of surgery matters. The article noted differences in the B-51/RTOG 1304 study between patients who had:
  • Breast-conserving surgery (lumpectomy)
  • Full breast removal (mastectomy)

In that study, the majority of patients underwent lumpectomy. All patients who had lumpectomy received radiation to the breast area, which may have indirectly treated nearby lymph nodes. This makes the results more complicated to interpret for mastectomy patients, particularly as recurrence rates were lower with radiation, even if the difference was not statistically significant.

• Shared decision-making is essential. The authors emphasized that treatment decisions should be individualized. Rather than applying one rule to everyone, doctors and patients should discuss:
  • Risks and benefits
  • Personal values
  • Potential side effects
  • Quality of life considerations
  • Long-term recurrence risk
  • The benefits of breast conserving therapy for most suitable patients

Community Impact

This research is important because it supports a more personalized approach to breast cancer care. For many patients, reducing unnecessary treatment could mean:

• Fewer side effects
• Lower treatment burden
• Less disruption to work and family life
• Reduced financial stress
• Improved quality of life

At the same time, the article highlights the importance of ensuring that treatment reductions do not unintentionally increase the risk of cancer returning, especially for patients who may still benefit from radiation therapy.

The publication also reinforces the importance of:

• Including patients in treatment decisions
• Considering patient experiences and priorities
• Continuing research that reflects real-world patient needs
• Developing more precise tools to identify who truly benefits from radiation therapy

Overall, the article reminds us that cancer treatment decisions are rarely “one size fits all.” The goal is not simply to provide less treatment, but to provide the right treatment for each individual patient.

Researcher: Robert W. Mutter, M.D.